We report that HSCs appear to play an important role in linking the process of hepatic granulomatous to hepatic fibrosis via NF-κB signaling, with miR-146 potentially modulating this process by targeting TRAF6, a key adapter molecules in the TLR4/NF-κB pathway. This evidence concerns the gene TLR4 and Hepatic fibrosis.